FHTX
FHTX clinical trials: Foghorn Therapeutics Inc.
Every trial on ClinicalTrials.gov where Foghorn Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 3
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
FHTX on the catalyst calendar · FHTX registry changes
- Primary completion Sep 2025Sponsor estimatePhase 1NCT04891757FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic MalignanciesFoghorn Therapeutics Inc. · Advanced Hematologic MalignancyActive, not recruitingFHTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 4, 2023ActualPhase 1NCT04965753FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss TumorsFoghorn Therapeutics Inc. · Advanced Synovial SarcomaTerminatedFHTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2023ActualPhase 1NCT04879017FHD-286 in Subjects With Metastatic Uveal MelanomaFoghorn Therapeutics Inc. · Metastatic Uveal MelanomaTerminatedFHTXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2031Sponsor estimatePhase 1NCT07941492A Trial of FHD-286 Plus Mosunetuzumab in Previously Treated Follicular LymphomaWeill Medical College of Cornell University · Follicular LymphomaNot yet recruitingFHTXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2028Sponsor estimatePhase 2NCT07551635SMARCA4/2 Inhibitor for POU2F3-Positive SCLCDana-Farber Cancer Institute · Small Cell Lung CancerRecruitingFHTXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2028Sponsor estimatePhase 1NCT07283094FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid LeukemiaMontefiore Medical Center · Acute Myeloid LeukemiaRecruitingFHTXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner